B. Braun Anticipates Becoming First to Deliver FDA Approved 2g Cefazolin
Harvest Technologies GmbH Appoints LifeCell International to Introduce its BMAC Technology to India
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Stiefel Laboratories Reaps First Fruits of Barrier Acquisition With Completion of Pivotal Phase III Clinical Trial for 200 mg Hyphanox(TM) (Itraconazole) Tablet
Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
Onyx Pharmaceuticals to Present at the Goldman Sachs 30th Annual Global Healthcare Conference
Diabetes Experts Applaud Supreme Court Judge Nominee Sonia Sotomayor for Successfully Meeting the Challenges of Type 1 Diabetes
ViroPharma to Present at Two June Healthcare Conferences
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
New Data Support Use of Simple Test to Predict Endometrial Cancer Response to Chemotherapy
FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting
IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
Findings in Epilepsy Gene in Animals May Guide Treatment Directions for Infants
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.